Grob Gerald N
Institute for Health, Health Care Policy, and Aging Research, 112 Paterson Street, Rutgers University, New Brunswick, NJ 08901, USA.
Perspect Biol Med. 2011 Autumn;54(4):417-37. doi: 10.1353/pbm.2011.0044.
At the beginning of the 21st century, fibromyalgia syndrome (FM) has become a diagnostic category that includes extremely large numbers of people, predominantly women. Yet only a few decades ago, FM (and its predecessor fibrositis) was of little interest or concern to either physicians or the general public. What, then, were the origins of the FM diagnosis, and why did its boundaries expand so rapidly during and after the 1980s? The answers to such questions are complex. Broad social and intellectual currents, internal developments within medicine, the appearance of a self-conscious women's movement, and the rise of an increasingly important pharmaceutical industry all converged to elevate the importance of FM. Yet the diagnosis has remained highly contested, and there are competing etiological theories and therapies.
在21世纪初，纤维肌痛综合征（FM）已成为一个涵盖大量人群的诊断类别，其中以女性为主。然而，仅仅几十年前，FM（及其前身纤维织炎）无论是对医生还是普通公众来说，都几乎没有引起兴趣或关注。那么，FM诊断的起源是什么，为什么在20世纪80年代期间及之后其范畴如此迅速地扩大呢？这类问题的答案很复杂。广泛的社会和思想潮流、医学内部的发展、自觉的妇女运动的出现以及日益重要的制药行业的兴起，所有这些因素共同作用，提升了FM的重要性。然而，该诊断仍然备受争议，并且存在相互竞争的病因理论和治疗方法。
